Guilin Sanjin sets the China IPO ball rolling
Guilin Sanjin Pharmaceutical Co, producer of Watermelon Frost throat lozenges, has won regulatory approval to sell as many as 46 million shares in an initial public offering on the Shenhzhen Stock Exchange. CFP |
Institutional and retail investors are waiting to see how the country's first-to-be listed company would perform on the bourses after the regulators lifted a nine-month ban on initial public offerings (IPOs) late last Thursday.
Photo